Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000192632 | SCV000232140 | benign | not specified | 2017-04-12 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000192632 | SCV000247386 | uncertain significance | not specified | 2014-07-18 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000192632 | SCV000250366 | benign | not specified | 2014-11-05 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV001082645 | SCV000287135 | benign | Heterotopia, periventricular, X-linked dominant; Melnick-Needles syndrome; Oto-palato-digital syndrome, type II; Frontometaphyseal dysplasia | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000244567 | SCV000319473 | likely benign | Cardiovascular phenotype | 2014-10-08 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics Inc | RCV000192632 | SCV000613321 | benign | not specified | 2017-03-06 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000720675 | SCV000851554 | likely benign | History of neurodevelopmental disorder | 2014-10-08 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000762689 | SCV000893025 | likely benign | not provided | 2018-12-01 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000762689 | SCV001158013 | benign | not provided | 2023-11-30 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000192632 | SCV004029210 | benign | not specified | 2023-07-30 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000762689 | SCV001808180 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000762689 | SCV001930310 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000762689 | SCV001969077 | likely benign | not provided | no assertion criteria provided | clinical testing |